Spain Oncology Drugs Market Analysis

Spain Oncology Drugs Market Analysis

$ 3999

By 2030, it is anticipated that the Spain oncology drugs market will reach a value of $8.5 Bn from $3.8 Bn in 2022, growing at a CAGR of 10.6% during 2022-2030. The oncology drug market in Spain is dominated by a few large pharmaceutical companies such as Highlight Therapeutics, Peptomyc, and Oryzon Genomics. The oncology market in Spain is segmented by different therapeutic areas, into breast cancer, lung cancer, colorectal cancer, prostate cancer, and others. The market is also segmented based on treatment type, such as surgery, radiation therapy, chemotherapy, and targeted therapy.

ID: IN10ESPH018 CATEGORY: Pharmaceuticals GEOGRAPHY: Spain AUTHOR: Dr. Vishwa Modhia

Buy Now

Spain Oncology Drugs Market Analysis Summary

By 2030, it is anticipated that the Spain oncology drugs market will reach a value of $8.5 Bn from $3.8 Bn in 2022, growing at a CAGR of 10.6% during 2022-2030. The oncology drug market in Spain is a significant market within the European Union. Spain has a high incidence of cancer and a strong healthcare system, which drives demand for oncology drugs.

In 2020, the incident number of cancer cases in Spain was 282,421. The cumulative risk of cancer was 47%, of which the maximum risk is for prostate cancer i.e., 16.2%. In 2020, the number of deaths by cancer in Spain was 186 per 100,000 patients. Healthcare spending in Spain was about $2,724 per capita in 2020, which was 10.7% of their GDP. Every third woman and every second man in Spain is a cancer patient. But along with that, in the past 20 years, there has been a 20% increase in the nation's cancer survival rate. Precision in diagnosis and cutting-edge medical techniques enable this.

spain oncology drugs market analysis

Market Dynamics

Market Growth Drivers Analysis

Due to the most recent developments in oncological therapy, about 60% of foreign patients choose Spain for cancer treatment, and roughly 70% of paediatric cancer patients receive successful treatment in Spanish hospitals. In Spain, the prevalence of cancer patients is also increasing. Every third woman and every second man in Spain is a cancer patient. The country’s cancer survival rate has increased by 20% in the past 20 years. This is made possible by accurate diagnosis and advanced treatment methods.

Competitive Landscape

Key Players

  • Oryzon Genomics (ESP)
  • Ona Therapeutics (ESP)
  • Peptomyc (ESP)
  • Highlight Therapeutics (ESP)
  • Aspen Europe
  • Hoffmann-La Roche Ltd
  • Novartis AG
  • Gilead Sciences Inc
  • Bayer AG

Notable Recent Deals

July 2022: Oryzon Genomics, a clinical-stage biopharmaceutical company leveraging oncological epigenetics to develop therapies in diseases with strong unmet medical needs, announced the start of a preclinical collaboration with the CMT Research Foundation (CMTRF), a U.S.-based patient-led, non-profit organization focused on delivering treatments and cures for Charcot-Marie-Tooth (CMT) disease, to explore Oryzon’s histone deacetylase 6 (HDAC6) inhibitors.

January 2020: Spain's Esteve sells a plant and then buys one as it refocuses on oncology drugs. Esteve, which is turning its focus toward branded and specialty drugs, has a deal to buy Berlin-based Riemser from private investment group Ardian. In the deal, Esteve gets a German manufacturing site and a portfolio of specialty drugs targeted at hospitals. Riemser primarily makes and sells oncology and neurology drugs as well as what it calls “niche therapies.”

Regulations and Reimbursement

Spain's citizens have access to cancer treatments through its national healthcare system. The nation's drug approval and regulation are handled by the Spanish Agency of Medicines and Medical Devices (AEMPS). The Spanish Public Health System (SNS)'s Pricing and Reimbursement (PR) is then established by the Inter-Ministerial Commission for the Pricing of Medicines (CIPM).

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company Overview Product Applications and Services Recent Developments Partnerships Ecosystem Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Oncology Drugs Market Segmentation

By Drug class

  • Cytotoxic drugs
    • Alkylating agents
    • Antimetabolites
    • Others
  • Targeted drugs
    • Monoclonal antibodies
    • Others
  • Hormonal drugs
  • Others

By Therapy

  • Chemotherapy
  • Targeted therapy
  • Immunotherapy

By Indication

  • Lung cancer
  • Stomach cancer
  • Colorectal cancer
  • Breast cancer
  • Prostate cancer
  • Others

By Dosage form

  • Solid
    • Tablets
    • Capsules
  • Liquid
  • Injectable
    • Prefilled syringes
    • Others

By Distribution channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • ?Others

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.


Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:



Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.



Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.

We value your inquiry and offer free customization with every report to fulfil your exact research needs.

This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 19 January 2023
Updated by: Anish Swaminathan

Related reports (by category)

Related reports (by geography)

subscribe to our newsletter